Century Therapeutics Cash Flow Statement (2020-2026) | IPSC

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-26.01M-28.15M-37.51M-30.99M-30.75M-31.68M-31.26M-33.29M-32.72M-39.40M-28.06M-31.21M-31.23M-35.67M76.56M-32.54M-34.42M-9.55M-90.91M-90.36M
Depreciation and Depletion (Quarter)
1.04M1.05M1.16M1.67M2.77M2.84M2.91M3.23M3.35M3.55M3.23M3.46M3.30M3.32M3.22M3.20M3.13M3.55M3.00M0.03M
Share-based Compensation (Quarter)
0.57M1.64M2.38M2.77M2.06M2.73M3.80M3.29M3.98M3.56M3.21M3.50M3.32M2.66M2.43M2.22M1.30M6.54M1.95M
Asset Writedowns and Impairment (Quarter)
4.22M12.14M4.33M6.76M
Cash from Operations (Quarter)
-23.98M-24.35M86.75M-25.56M-24.24M-22.91M-29.22M-19.25M-13.65M-26.23M-30.25M-27.33M-28.33M-24.22M-34.62M-27.59M-25.58M-16.10M-25.26M-19.83M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
1.11M1.34M1.32M1.03M0.85M0.65M0.51M0.35M0.21M0.15M
Amortization of Deferred Charges (Quarter)
0.08M0.08M0.08M0.08M0.08M0.07M0.06M0.04M
Depreciation & Amortization (CF) (Quarter)
1.04M1.05M1.16M1.67M2.77M2.84M2.91M3.23M3.35M3.55M3.23M3.46M3.30M3.32M3.22M3.20M3.13M3.55M3.00M0.03M
Change in Working Capital
Change in Account Payables (Quarter)
-0.58M2.29M-1.50M-2.36M0.71M-1.63M-2.95M-0.51M3.99M-2.89M0.69M-1.88M-0.76M0.48M0.36M-0.36M-0.59M2.16M-1.62M1.67M
Change in Accured Expenses (Quarter)
0.38M-1.19M-1.17M2.27M1.73M1.13M-3.21M1.93M2.93M-2.39M-3.32M-0.24M2.25M2.91M-6.54M0.71M0.44M1.08M-3.96M1.16M
Other Working Capital Changes (Quarter)
0.50M0.19M-1.03M121.77M-120.34M117.59M-1.72M1.99M-0.68M-0.26M-0.85M2.98M-4.54M1.87M-0.29M-0.15M-108.73M0.06M1.16M
Investing Activities
Capital Expenditures (Quarter)
-4.81M-6.34M4.07M10.46M9.81M-21.68M4.99M4.50M3.27M0.98M0.54M0.27M0.47M0.32M0.20M-0.14M0.58M0.69M
Change in Acquisitions & Divestments (Quarter)
14.76M38.01M63.09M57.20M98.86M52.33M79.16M110.49M64.98M29.27M47.17M29.87M51.57M48.18M43.29M42.52M35.89M37.82M28.66M34.37M
Cash from Investing Activities (Quarter)
-147.05M-20.60M-44.04M12.52M22.66M-4.27M31.34M6.97M4.22M18.60M11.54M-33.86M39.20M30.61M27.93M32.54M24.67M22.36M-112.61M17.77M
Financing Activities
Other financing activities (Quarter)
219.12M
Cash from Financing Activities (Quarter)
-0.47M0.11M26.88M0.05M0.14M0.10M0.45M-10.12M0.30M-0.36M18.20M56.70M0.27M-0.60M0.12M0.05M126.62M0.31M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-159.50M159.50M0.07M0.05M0.14M0.10M0.45M0.12M0.30M-0.36M0.37M0.10M0.27M-0.60M0.12M0.05M0.20M0.35M
Additional items
Change in Cash (Quarter)
-171.50M-44.85M69.59M-12.99M-1.44M-27.09M2.57M-22.39M-9.13M-7.98M-0.51M-4.50M11.14M5.78M-6.57M4.95M-0.91M6.34M-11.25M-1.76M
Free Cash Flow (Quarter)
-19.17M-18.01M82.69M-36.01M-34.05M-1.23M-34.21M-23.75M-16.91M-27.21M-30.79M-27.60M-28.33M-24.22M-35.10M-27.91M-25.78M-15.96M-25.85M-20.53M
Net Cash Flow (Quarter)
-171.50M-44.85M69.59M-12.99M-1.44M-27.09M2.57M-22.39M-9.13M-7.98M-0.51M-4.50M11.14M5.78M-6.57M4.95M-0.91M6.31M-11.25M-1.76M